« Why Define the Neurotechology Industry? |
Main
| Arab Strategy Forum to Visit Our Emerging Neurosociety »
November 29, 2004
Venture Philanthropy and FasterCures for Mental Health
Posted by Zack Lynch
As foundations, private enterprise and governments continue their struggle to develop better therapies for neurological disorders faster, venture philanthropy is looking to shift the entire landscape. Most specifically, FasterCures, formed under the auspices of the Milken Institute, is boldly challenging all aspects of "the complex machinery that drives breakthroughs in medicine work."
The FasterCures Acceleration agenda addresses four key areas:
1. Science and Technology
2. Law and Regulation
3. Economics and Finance
4. Social Issues and Ethics
I highly recommend following this link to their position on increasing incentives for medical cures. It pinpoints why defining the neurotechnology industry will accelerate faster, more targeted cures for mental illness.
Update: Barron's - the cover story of the latest issue of Barron's is entitled: "Stategic giving - A Special Report on Philanthropy -- Business principles are reshaping the charitable world. Five nonprofits to watch.These new players are saying that maybe if we take the best of the business world and the best of philanthropy, we could get some traction on solving these problems," says Elizabeth Bremner, president of the Palo Alto., Calif.-based Foundation Incubator, an organization that helps newly-minted Silicon Valley millionaires get charitable ventures up and running."
Comments (0)
+ TrackBacks (0) | Category: Brain Foundations
- RELATED ENTRIES
- Neurotech 2010: Translational Researchers Highlight Innovation
- The Neuro Revolution in China Progressing
- Speakers for Neurotech 2010 - Boston, May 19-20
- Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
- McGovern Institue for Brain Research at MIT Goes Web 2.0
- The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
- Neuropharma FDA Approvals Down in 2009
- Tel Aviv Neurotech Cluster Thrives